Paper900147
Resolution of renal amyloidosis.
Dikman SH and 3 others. Am J Med, 1977. Cited by 88 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Resolution of renal amyloidosis. Papers, record 900147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/900147
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyloidosis | Major topic |
| Kidney Diseases | Major topic |
| Basement Membrane | |
| Biopsy | |
| Capillaries | |
| Child | |
| Humans | |
| Kidney Glomerulus | |
| Male | |
| Nephrotic Syndrome | |
| Remission, Spontaneous |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,616,421 | Grand rounds--Hammersmith Hospital. Reactive (AA) systemic amyloidosis. A cause of refractory nephrotic syndrome. | BMJ | 1996 | https://conductscience.org/library/papers/8616421 | PubMed |
| 8,305,072 | Xanthogranulomatous pyelonephritis and amyloidosis. | Pediatr Nephrol | 1993 | https://conductscience.org/library/papers/8305072 | PubMed |
| 8,124,919 | Colchicine induced remission in amyloid nephrotic syndrome. | Clin Rheumatol | 1993 | https://conductscience.org/library/papers/8124919 | PubMed |
| 7,742,218 | Secondary amyloidosis from long-standing bacterial endocarditis. | Pediatr Nephrol | 1995 | https://conductscience.org/library/papers/7742218 | PubMed |
| 7,442,080 | Human glomerular amyloidosis -- with special regard to proteinuria and amyloidogenesis. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/7442080 | PubMed |
| 6,881,286 | AA protein-related renal amyloidosis in drug addicts. | Am J Pathol | 1983 | https://conductscience.org/library/papers/6881286 | PubMed |
| 3,671,242 | Amyloid myopathy and myeloma: response to treatment. | Postgrad Med J | 1987 | https://conductscience.org/library/papers/3671242 | PubMed |
| 3,500,678 | Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease. | Ann Rheum Dis | 1987 | https://conductscience.org/library/papers/3500678 | PubMed |
| 2,242,306 | Renal amyloidosis in juvenile chronic arthritis: evolution after chlorambucil treatment. | Pediatr Nephrol | 1990 | https://conductscience.org/library/papers/2242306 | PubMed |
| 2,187,962 | Medical complications of intravenous drug use. | J Gen Intern Med | 1990 | https://conductscience.org/library/papers/2187962 | PubMed |
| 1,329,309 | Significance of fibrils in the formation of the Kimmelstiel-Wilson nodule. | Virchows Arch A Pathol Anat Histopathol | 1992 | https://conductscience.org/library/papers/1329309 | PubMed |
| 157,620 | Ultrastructural studies on the evolution of amyloidosis in the cyclic hematopoietic (CH) dog. | Virchows Arch A Pathol Anat Histol | 1979 | https://conductscience.org/library/papers/157620 | PubMed |
| 150,693 | Investigations on the cause of the nephrotic syndrome in renal amyloidosis. A discussion of electron microscopic findings. | Virchows Arch A Pathol Anat Histol | 1978 | https://conductscience.org/library/papers/150693 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/900147
GET https://conductscience.org/api/papers/v1/900147/authors